Literature DB >> 3041036

A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene.

G W Kemble, A L McCormick, L Pereira, E S Mocarski.   

Abstract

We demonstrated the presence of a single-stranded DNA-binding protein in human cytomegalovirus (CMV)-infected cells with properties analogous to those of herpes simplex virus (HSV) ICP8. Using monoclonal antibody specific for the CMV protein, we analyzed its fluorescence pattern and time of synthesis, mapped the gene encoding it by using a lambda gt11 library of CMV DNA fragments, and monitored its purification by phosphocellulose and DNA-Sepharose chromatography. In all characteristics we examined, the CMV protein behaved analogously to HSV ICP8. Our results are consistent with a functional role of CMV ICP8 in viral replication that is similar to that of HSV ICP8 and with the evolutionary conservation of the gene of interest in two divergent herpesviruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3041036      PMCID: PMC255891          DOI: 10.1128/JVI.61.10.3143-3151.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  DNA-negative temperature-sensitive mutants of herpes simplex virus type 1: patterns of viral DNA synthesis after temperature shift-up.

Authors:  P A Schaffer; D R Bone; R J Courtney
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Experimental studies on the antiherpetic agent phosphonoformic acid.

Authors:  E Helgstrand; B Oberg; S Alenius
Journal:  Adv Ophthalmol       Date:  1979

3.  Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants.

Authors:  L S Morse; L Pereira; B Roizman; P A Schaffer
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

4.  Covalent attachment of DNA to agarose. Improved synthesis and use in affinity chromatography.

Authors:  D J Arndt-Jovin; T M Jovin; W Bähr; A M Frischauf; M Marquardt
Journal:  Eur J Biochem       Date:  1975-06

Review 5.  Genome variation and evolution among herpes viruses.

Authors:  B Roizman
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

6.  Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection.

Authors:  M W Wathen; M F Stinski
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

7.  Human cytomegalovirus DNA: physical maps for restriction endonucleases BglII, hindIII and XbaI.

Authors:  M W Weststrate; J L Geelen; J van der Noordaa
Journal:  J Gen Virol       Date:  1980-07       Impact factor: 3.891

8.  Nonstructural proteins of herpes simplex virus. II. Major virus-specific DNa-binding protein.

Authors:  K L Powell; E Littler; D J Purifoy
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

9.  Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus.

Authors:  E S Huang; J S Pagano
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

10.  Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides.

Authors:  A J Conley; D M Knipe; P C Jones; B Roizman
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

View more
  23 in total

1.  The carboxy-terminal segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is crucial for viral replication.

Authors:  Laurie A Silva; Arianna Loregian; Gregory S Pari; Blair L Strang; Donald M Coen
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Cloning and characterization of major antigenic determinants of human cytomegalovirus Ad169 seen by the human immune system.

Authors:  W Lindenmaier; A Necker; S Krause; R Bonewald; J Collins
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Multicomponent origin of cytomegalovirus lytic-phase DNA replication.

Authors:  D G Anders; S M Punturieri
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 4.  Molecular biology of cytomegalovirus.

Authors:  V C Emery; P D Griffiths
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

5.  Identification of the lytic origin of DNA replication in human cytomegalovirus by a novel approach utilizing ganciclovir-induced chain termination.

Authors:  F M Hamzeh; P S Lietman; W Gibson; G S Hayward
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids.

Authors:  G Kemble; G Duke; R Winter; R Spaete
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region.

Authors:  R M Stenberg; A S Depto; J Fortney; J A Nelson
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

8.  The DNA-binding properties of immediate-early and early proteins of murine cytomegalovirus.

Authors:  D G Walker; J B Hudson
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

9.  Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication.

Authors:  G S Pari; D G Anders
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Cyclin-dependent kinase activity is required at early times for accurate processing and accumulation of the human cytomegalovirus UL122-123 and UL37 immediate-early transcripts and at later times for virus production.

Authors:  Veronica Sanchez; Anita K McElroy; Judy Yen; Sama Tamrakar; Charles L Clark; Rachel A Schwartz; Deborah H Spector
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.